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Introduction. The association of gonadal dysgenesis and Mayer-Rokitansky-Kuster-Hauser syndrome is very rare and appears to
be coincidental, independent of chromosomal anomalies. Case Report. We report the case of a 19-year-old woman who presented
primary amenorrhea and impuberism. The endocrine study revealed hypergonadotrophic hypogonadism. The karyotype was
normal, 46XX. No chromosome Y was detected at the FISH analysis. Internal genitalia could not be identiﬁed on the pelvic
ultrasound and pelvic MRI. Laparoscopy was undertaken and revealed concomitant ovarian dysgenesis and Mayer-Rokitansky-
Kuster-Hauser syndrome. There were no other morphological malformations. Conclusion. The pathogenesis of the association
of gonadal dysgenesis and Mayer Rokitansky kuster hauser syndrome is still mysterious. The treatment is based essentially on
hormone substitution therapy. The fertility prognosis is unfortunately compromised.
1.Introduction
Gonadal dysgenesis with female phenotype is deﬁned as the
absence or insuﬃcient development of the ovaries. It causes
primary amenorrhea with variable hypogonadism or impu-
berism, depending on the degree of gonadal development.
The karyotype can be 46,XX; 45,X0; 46,XY or mosa¨ ıcism
45,X/46,XX; 45,X/46,X,del(X)(p22.2); 46,X,i(Xq) [1–3]. The
Mayer-Rokitansky-Kuster-Hauser Syndrome (MRKHS) is a
speciﬁc type of mullerian duct malformation characterized
by congenital absence or hypoplasia of uterus and upper two
thirds of the vagina in both phenotypically and karyotyp-
ically normal females with functional ovaries [4]. It is the
second most common cause of primary amenorrhea.
An association between these two conditions is very
exceptional and appears to be coincidental, independent of
chromosomal anomalies.
2.CaseReport
We report the case of a 19-year-old Moroccan woman who
presented primary amenorrhea and impuberism.
Herheightwas168cm,weight54Kg,andbloodpressure
120/70mmHg. No other aﬀected members family were
detected. Physical examination revealed no abnormalities.
Pubic, axillary hair growth and breast development were
scored, respectively, Tanner stages II and III. The patient had
no evidence of facial dysmorphism, webbing of the neck,
or skeletal abnormalities. A 1cm vagina ending in a blind
pouch was found on gynecological examination. Bimanual
pelvic and rectovaginal examination revealed no evidence of
ac e r v i xo ru t e r u s .
An endocrine study including pituitary, ovarian, and
thyroid evaluation was performed and reveled hyper-
gonadotrophic hypogonadism (Luteinizing Hormone:
16.07UI/L, Follicle Stimulating Hormone: 42.48UI/L,
Oestradiol: 24.24UI/L) with normal level of prolactin and
Thyroid Stimulating Hormone. The karyotype was 46XX
(Figure 1), and no Y chromosome material was detected in
ﬂuorescence in situ hybridization (FISH). Internal genitalia
could not be identiﬁed on the pelvic ultrasound (Figure 2)
nore on the IRM (Figures 3 and 4). Laparoscopy was
undertaken and revealed concomitant ovarian dysgenesis
and Mayer-Rokitansky-Kuster-Hauser syndrome.2 Obstetrics and Gynecology International
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Figure 1: Fluorescence in situ hybridization FISH: the chromo-
somes can be seen in blue LSI SRY: spectrum orange/CEP X:
spectrum green. Presence of 2 green spots. No orange spot was
detected.
Figure 2: Ultrasound exam: no uterus identiﬁed behind the
bladder.
Bone study, pelvic ultrasound, and laparoscopic study
were ordered to evaluate the associated genitourinary and
skeletal anomalies. There were no other morphological
malformations.
We conclude to an association of MRKH with ovarian
agenesis. Hormonal substitution by estrogen and proges-
terone was then undertaken.
3. Discussion
T h eo v a r i e sa r ee m b r y o l o g i c a l l yd e r i v e df r o m3s o u r c e s :
mesodermal epithelium (lining the posterior or abdomi-
nal wall), underlying mesenchyme (embryonic connective
tissue), and primordial germ cells. The epithelium and
mesenchyme proliferate to produce the genital (gonadal)
ridge. The primordial germ cells migrate along the dorsal
mesentery of the hindgut to the genital ridges and enter the
underlying mesenchyme. If the primordial germ cells do not
Figure 3: Magnetic resonance imaging (MRI): axial plane cut
showing bladder and rectum without interposition of uterus.
Figure 4:MRIexaminationsagittalplanecut:absenceofuterusand
ovaries.
form or migrate into the gonadal area, an ovary will not
develop.
The mullerian (paramesonephric) ducts develop lateral
tothegonadsandplayanessentialroleinthedevelopmentof
uterine tubes, uterus, superior part of the vagina and broad
ligaments. Estrogens may inﬂuence development of the
paramesonephric system. Absence of mullerian-inhibiting
substance (antimullerian hormone) is also essential for its
development. Mutations of the gene encoding the antimul-
lerian hormone receptor and the lack of estrogen receptors
during embryonic development have been hypothesized to
cause MRKH syndrome [2].
An undiﬀerentiated gonad may produce antimullerian
hormone in earlier embryologic period. But this hypothesis
cannot be valuable without the presence of the chromosome
Y[ 5]. The FISH analysis of karyotype of our patient
demonstrated the absence of chromosome Y.Obstetrics and Gynecology International 3
Few cases of association of ovarian dysgenesis and
MRKH syndrome are reported in the literature indeed
[1, 2, 6–10].
Unfortunately these two conditions compromise the
prognosis of fertility of young patients.
Hormone substitution therapy remains the only thera-
peutic option. It is aimed at triggering the development of
secondary sexual characters and prevent osteoporosis. There
remains the unsolved problem of infertility [6].
4. Conclusion
The association of gonadal dysgenesis and Mayer Rokitansky
kuster hauser syndrome is very rare and appears to be coin-
cidental,independent ofchromosomalanomalies. Thesetwo
conditions compromise the fertility both in the mechanic
and hormonal plane. Actually the treatment is based on
hormone substitution therapy. The aim of the treatment is to
trigger the development of secondary sexual characters and
prevent osteoporosis.
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